<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Clin Invest</journal-id><journal-id journal-id-type="iso-abbrev">Eur. J. Clin. Invest</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1365-2362</journal-id><journal-id journal-id-type="publisher-id">ECI</journal-id><journal-title-group><journal-title>European Journal of Clinical Investigation</journal-title></journal-title-group><issn pub-type="ppub">0014-2972</issn><issn pub-type="epub">1365-2362</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7235512</article-id><article-id pub-id-type="doi">10.1111/eci.13225</article-id><article-id pub-id-type="publisher-id">ECI13225</article-id><article-categories><subj-group subj-group-type="overline"><subject>Letter to the Editor</subject></subj-group><subj-group subj-group-type="heading"><subject>Letters to the Editor</subject></subj-group></article-categories><title-group><article-title>Improving communication about COVID&#x02010;19 and emerging infectious diseases</article-title></title-group><contrib-group><contrib id="eci13225-cr-0001" contrib-type="author" corresp="yes"><name><surname>Jacobsen</surname><given-names>Kathryn H.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4198-6246</contrib-id><xref ref-type="aff" rid="eci13225-aff-0001">
<sup>1</sup>
</xref><address><email>kjacobse@gmu.edu</email></address></contrib><contrib id="eci13225-cr-0002" contrib-type="author"><name><surname>Vraga</surname><given-names>Emily K.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3016-3869</contrib-id><xref ref-type="aff" rid="eci13225-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="eci13225-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Global and Community Health</named-content>
<institution>George Mason University</institution>
<city>Fairfax</city>
<named-content content-type="country-part">VA</named-content>
<country country="US">USA</country>
</aff><aff id="eci13225-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Hubbard School of Journalism and Mass Communication</named-content>
<institution>University of Minnesota</institution>
<city>Minneapolis</city>
<named-content content-type="country-part">MN</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Kathryn H. Jacobsen, Department of Global and Community Health, George Mason University, 4400 University Drive 5B7, Fairfax, VA 22030, USA.<break/>
Email: <email>kjacobse@gmu.edu</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2020</year></pub-date><elocation-id>e13225</elocation-id><history><date date-type="received"><day>26</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>05</day><month>4</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 Stichting European Society for Clinical Investigation Journal Foundation <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 Stichting European Society for Clinical Investigation Journal Foundation</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:ECI-9999-e13225.pdf"/><counts><fig-count count="0"/><table-count count="0"/><page-count count="2"/><word-count count="1145"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.2 mode:remove_FC converted:19.05.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="eci13225-body-0001"><p>John Ioannidis writes about the harm caused by misinformation about COVID&#x02010;19.<xref rid="eci13225-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> We draw from communication research to offer best practices for reducing misinformation, disseminating accurate health information and promoting prevention and control recommendations. We recommend three strategies that medical, public health and scientific professionals working with government officials, clinicians, media commentators and in other contexts around the world can use to improve communication about outbreaks.</p><p>First, we can acknowledge uncertainty. Public trust is damaged when health authorities are perceived to have inappropriately downplayed the true risk posed by a dangerous pathogen or, alternatively, to have caused undue panic by overstating a potential threat. Honesty about what is known and what is not known at each stage of an epidemic is a critical component of transparency.<xref rid="eci13225-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> For example, model&#x02010;based projections about how epidemics might expand should be reported as likely ranges of mild&#x02010;to&#x02010;severe events rather than just presenting best&#x02010; or worst&#x02010;case scenarios.</p><p>Second, we can contextualize statistics. Most people find it difficult to estimate personal risk based on population&#x02010;level data, especially for relatively unlikely occurrences.<xref rid="eci13225-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> One way to mitigate excessive anxiety related to rising case counts is to pair discussion of personal, community or national risk with recommendations about concrete, evidence&#x02010;based actions that reduce risk.<xref rid="eci13225-bib-0004" ref-type="ref">
<sup>4</sup>
</xref> These suggestions should be specific to the disease of concern, and the recommendations should be updated as more scientific evidence becomes available.</p><p>Third, we can resist misinformation. Uncertainty breeds rumours and confusion, and social media platforms offer a fertile space for misinformation to be generated and disseminated. Accurate information provided by trusted clinicians and scientists can help mitigate the spread of misinformation that is damaging to public health. Health communication specialists may be able to directly counter prominent false narratives while promoting reliable sources of health information.<xref rid="eci13225-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> Health professionals who are not trained on methods for combatting misinformation can, at minimum, refrain from propagating it.</p><p>Effective communication about public health is a challenge even without the heightened fear levels that occur when new diseases like COVID&#x02010;19 emerge. Even when messaging about a health security threat is constrained by politics, media practices and other limiters, the three guidelines above can still be applied in communications with the public, the media and other audiences. Acknowledging uncertainty, contextualizing statistics and resisting misinformation will improve communication about emerging infectious diseases from the initial crisis through the resolution of the event.</p><sec sec-type="COI-statement" id="eci13225-sec-0002"><title>CONFLICTS OF INTEREST</title><p>None to declare.</p></sec></body><back><ref-list content-type="cited-references" id="eci13225-bibl-0001"><title>REFERENCES</title><ref id="eci13225-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="eci13225-cit-0001">
<string-name>
<surname>Ioannidis</surname>
<given-names>JPA</given-names>
</string-name>, <article-title>Coronavirus disease 2019: the harms of exaggerated information and non&#x02010;evidence&#x02010;based measures</article-title>. <source xml:lang="en">Eur J Clin Invest</source>. <year>2020</year>;<volume>50</volume>: <pub-id pub-id-type="doi">10.1111/eci.13222</pub-id>
</mixed-citation></ref><ref id="eci13225-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="eci13225-cit-0002">
<string-name>
<surname>O&#x02019;Malley</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Rainford</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Thompson</surname>
<given-names>A</given-names>
</string-name>. <article-title>Transparency during public health emergencies: from rhetoric to reality</article-title>. <source xml:lang="en">Bull World Health Organ</source>. <year>2009</year>;<volume>87</volume>:<fpage>614</fpage>&#x02010;<lpage>618</lpage>.<pub-id pub-id-type="pmid">19705012</pub-id></mixed-citation></ref><ref id="eci13225-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="eci13225-cit-0003">
<string-name>
<surname>Schwartz</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Woloshin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Welch</surname>
<given-names>HG</given-names>
</string-name>. <article-title>Risk communication in clinical practice: putting cancer in context</article-title>. <source xml:lang="en">J Natl Cancer Inst Monogr</source>. <year>1999</year>;<volume>25</volume>:<fpage>124</fpage>&#x02010;<lpage>133</lpage>.</mixed-citation></ref><ref id="eci13225-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="eci13225-cit-0004">
<string-name>
<surname>Witte</surname>
<given-names>K</given-names>
</string-name>. <article-title>Generating effective risk messages: how scary should your risk communication be?</article-title>
<source xml:lang="en">Ann Int Commun Assoc</source>. <year>1995</year>;<volume>18</volume>:<fpage>229</fpage>&#x02010;<lpage>254</lpage>.</mixed-citation></ref><ref id="eci13225-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="eci13225-cit-0005">
<string-name>
<surname>Vraga</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Bode</surname>
<given-names>L</given-names>
</string-name>. <article-title>Using expert sources to correct health misinformation in social media</article-title>. <source xml:lang="en">Sci Commun</source>. <year>2017</year>;<volume>39</volume>:<fpage>621</fpage>&#x02010;<lpage>645</lpage>.</mixed-citation></ref></ref-list></back></article>